WPI, International Institute for Carbon-Neutral Energy Research (WPI-I2CNER), Kyushu University, Fukuoka, Japan.
School of Applied Sciences, University of Campinas (UNICAMP), Limeira, São Paulo, Brazil.
Mater Sci Eng C Mater Biol Appl. 2020 Jul;112:110908. doi: 10.1016/j.msec.2020.110908. Epub 2020 Mar 30.
Despite significant studies on mechanical properties of high-entropy alloys (HEAs), there have been limited attempts to examine the biocompatibility of these alloys. In this study, a lattice-softened high-entropy alloy TiAlFeCoNi with ultrahigh hardness (examined by Vickers method), low elastic modulus (examined by nanoindentation) and superior activity for cell proliferation/viability/cytotoxicity (examined by MTT assay) was developed by employing imperial data and thermodynamic calculations. The designated alloy after casting was processed further by high-pressure torsion (HPT) to improve its hardness via the introduction of nanograins, dislocations and order-disorder transformation. The TiAlFeCoNi alloy with the L2-BCC crystal structure exhibited 170-580% higher hardness and 260-1020% better cellular metabolic activity compared to titanium and Ti-6Al-7Nb biomaterials, suggesting the high potential of HEAs for future biomedical applications.
尽管人们对高熵合金(HEAs)的力学性能进行了大量研究,但对这些合金的生物相容性的研究却很有限。在这项研究中,通过采用帝国数据和热力学计算,开发出了一种具有超高硬度(通过维氏法测试)、低弹性模量(通过纳米压痕测试)和优异细胞增殖/活力/细胞毒性(通过 MTT 测定法测试)的晶格软化高熵合金 TiAlFeCoNi。在铸造后,指定的合金通过高压扭转(HPT)进一步加工,通过引入纳米晶粒、位错和有序-无序转变来提高其硬度。具有 L2-BCC 晶体结构的 TiAlFeCoNi 合金的硬度比钛和 Ti-6Al-7Nb 生物材料高 170-580%,细胞代谢活性高 260-1020%,表明 HEAs 在未来生物医学应用中有很高的潜力。